Skip to main content
Signal8
Launch Terminal

Brainsway Ltd. (BWAY)

BrainsWay Ltd. develops and distributes non-invasive neurostimulation therapies that address a broad spectrum of mental health and neurological conditions. The company operates globally, with a presence in the United States, Europe, and Israel, among other international markets. Its primary offering is the Deep Transcranial Magnetic Stimulation (dTMS) platform technology, which provides treatment for various ailments including major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post-stroke rehabilitation, and Parkinson's disease. BrainsWay's clientele primarily comprises medical professionals, hospitals, and medical centers specializing in psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Specialties

BrainsWay Ltd. logo

BrainsWay Ltd.

NASDAQ:BWAYHealthcare
-4.78%$11.36
AH$11.36+0.00%vs close
Mkt Cap$457.27M
Float25.13M
O/S40.25M
Vol
$ Vol
RVOL
Inst Own28.8%
SI0.9%
Earnings
Dilution
BrainsWay Ltd. logoNASDAQ:BWAY$11.36-4.78%
Phase Distribution
21 lead-sponsored trials·1 active·8 completed
Early Phase 11
Phase 12
Phase 24
Phase 31
Phase 41
Not applicable12
(19 more as collaborator)
Status Overview
Recruiting1
Completed8
Stopped5
Unknown7

Trials need funding. See this company's dilution risk and cash position.

Clinical Trials
Sponsor role
Status
Phase
  • Phase 4
    Completed

    Brainsway DTMS for Treatment of MDD Using iTBS

    Brainsway DTMS with intermittent Theta Burst Stimulation (iTBS), Brainsway DTMS with High Frequency (HF) Stimulation

    Major Depressive Disorder

    Enrollment
    177
    Start
    Jan 2019
    Primary Completion
    Jul 2020
    Completion
    Jul 2020
    NCT04679753
  • Phase 3
    Completed

    Evaluation of Deep Transcranial Magnetic Stimulation (DTMS) With the H-ADD Coil as an Aid to Smoking Cessation.

    Sham Treatment, Active dTMS Treatment

    Smoking Cessation

    Enrollment
    224
    Start
    Aug 2014
    Primary Completion
    Nov 2019
    Completion
    Nov 2019
    NCT02126124
  • Phase 2
    Completed

    Deep Transcranial Magnetic Stimulation for Treatment of Alzheimer's Disease

    TMS, H coil

    Alzheimer's Disease

    Enrollment
    45
    Start
    Aug 2010
    Primary Completion
    Jan 2015
    Completion
    Jun 2015
    NCT01179373
  • Phase 2
    Terminated

    Deep rTMS (Repetitive Transcranial Magnetic Stimulation)for Treatment of Autism Symptoms in Children.

    Transcranial Magnetic Stimulation

    Autism

    Enrollment
    20
    Start
    Jan 2013
    Primary Completion
    Dec 2016
    Completion
    Dec 2016
    NCT01388179
  • Phase 2
    Completed

    The Influence of Deep TMS on Cerebellar Signs in Patients With Machado Joseph Disease

    Deep TMS

    Machado Joseph Disease (SCA3)

    Enrollment
    20
    Start
    Feb 2014
    Primary Completion
    Feb 2015
    Completion
    Jun 2016
    NCT02039206
  • Phase 2
    Withdrawn

    Deep TMS of the Left Auditory Cortex Using the HMCIPCC Coil, in the Treatment of Patients With Tinnitus.

    Deep Transcranial Magnetic Stimulation, Deep Transcranial Magnetic Stimulation

    Tinnitus

    Enrollment
    0
    Start
    Jan 2014est.
    Primary Completion
    Jan 2016est.
    Completion
    Jan 2016est.
    NCT02053961
  • Phase 1
    Unknown status

    Deep Transcranial Magnetic Stimulation (DTMS) as a Treatment for Attention Deficit Hyperactivity Disorder (ADHD) in Adults

    treatment by HLPFC coil

    Attention Deficit Hyperactivity Disorder

    Enrollment
    45
    Start
    Jul 2011
    Primary Completion
    Sep 2020est.
    Completion
    Sep 2020est.
    NCT01196910
  • Phase 1
    Unknown status

    Efficiency of Deep Transcranial Magnetic Stimulation on Patients With Mild Cognitive Impairment

    H-Coil Deep TMS, SHAM Coil TMS

    Mild Cognitive Impairment

    Enrollment
    30
    Start
    Jan 2021est.
    Primary Completion
    Jan 2021est.
    Completion
    Jan 2021est.
    NCT01464515
  • Early Phase 1
    Withdrawn

    Facilitating Associative Memory Via Deep Transcranial Magnetic Stimulation to the Medial Temporal Lobe

    TMS

    Effect of Deep Transcranial Magnetic Stimulation on Memory

    Enrollment
    0
    Start
    Aug 2012
    Primary Completion
    Jan 2015est.
    Completion
    Jun 2015est.
    NCT01599208
  • Not applicable
    Completed

    Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder

    Brainsway H-Coil Deep TMS System, Brainsway H-Coil Deep TMS System (Sham treatment)

    Major Depressive Disorder

    Enrollment
    233
    Start
    Sep 2009
    Primary Completion
    Mar 2012
    Completion
    Jun 2012
    NCT00927173
  • Not applicable
    Unknown status

    Tolerability, Safety and Efficacy of the HAC-Coil Deep Transcranial Magnetic Stimulation in Medication Resistance Obsessive Compulsive Disorder (OCD) Subjects

    Deep TMS

    Obsessive Compulsive Disorder

    Enrollment
    40
    Start
    Jun 2011
    Primary Completion
    Nov 2020est.
    Completion
    Nov 2020est.
    NCT01343732
  • Not applicable
    Completed

    Prospective Multicenter Trial to Explore the Tolerability and Safety of the H-Coil Deep TMS in Combination With Serotonin Selective Reuptake Inhibitor(SSRI)

    H-Coil Deep TMS in combination with SSRIs

    Major Depressive Disorder, Recurrent, Unspecified, Major Depressive Disorder, Single Episode, Unspecified

    Enrollment
    75
    Start
    Jul 2011
    Primary Completion
    Dec 2014
    Completion
    Dec 2014
    NCT01361815
  • Not applicable
    Unknown status

    Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

    Deep TMS Treatment, Sham Treatment

    Bipolar Depression

    Enrollment
    120
    Start
    May 2012
    Primary Completion
    Dec 2021est.
    Completion
    Dec 2021est.
    NCT01566591
  • Not applicable
    Completed

    An Evaluation of the Safety and Efficacy of the dTMS Treatment for OCD

    Active DTMS Treatment, Sham Treatment

    Obsessive Compulsive Disorder

    Enrollment
    100
    Start
    Sep 2014
    Primary Completion
    Jun 2017
    Completion
    Jun 2017
    NCT02229903
  • Not applicable
    Withdrawn

    Post Marketing Study to Evaluate the Resource Utilization of Patients Suffering From Resistant Depression Treated With Deep TMS in Comparison to Treatment as Usual

    dTMS

    Depression

    Enrollment
    0
    Start
    Oct 2014
    Primary Completion
    Sep 2020est.
    Completion
    Sep 2020est.
    NCT02260765
  • Not applicable
    Terminated

    A Safety & Efficacy Study With Deep Transcranial Magnetic Stimulation for the Treatment of Post-Traumatic Stress Disorder (PTSD)

    Deep TMS System, Sham Treatment

    Post-Traumatic Stress Disorder

    Enrollment
    203
    Start
    Nov 2016
    Primary Completion
    Feb 2020
    Completion
    Mar 2020
    NCT02479906
  • Not applicable
    Unknown status

    Efficacy of H7-Coil DTMS Compared to H1-Coil DTMS in Subjects With Major Depression Disorder (MDD)

    H7-Coil, H1-Coil

    Major Depressive Disorder (MDD)

    Enrollment
    106
    Start
    Mar 2017
    Primary Completion
    Dec 2020est.
    Completion
    Dec 2020est.
    NCT03012724
  • Observational
    Unknown status

    Combining H1-Coil Deep Transcranial Magnetic Stimulation (dTMS) and App-guided CBT in Subjects With Major Depression Disorder (MDD)

    CBT-based, mobile-delivered, intervention platform

    Data Collection for Facilitation of Machine Learning Algorithm for Personalized Treatment

    Enrollment
    540
    Start
    Aug 2019
    Primary Completion
    Aug 2021est.
    Completion
    Aug 2021est.
    NCT04455646
  • Not applicable
    Unknown status

    Evaluation of the Long Term Efficacy and Durability of the BrainsWay Deep TMS in OCD Subjects

    BrainsWay Deep TMS HAC/H7-Coil, BrainsWay Deep TMS Sham Coil

    Obsessive-Compulsive Disorder

    Enrollment
    124
    Start
    Aug 2022est.
    Primary Completion
    Jun 2024est.
    Completion
    Jun 2024est.
    NCT05404360
  • Not applicable
    Completed

    New Investigational Stimulation Protocol for Treatment of Major Depression Disorder (MDD)

    Brainsway Deep TMS System

    Major Depressive Disorder

    Enrollment
    104
    Start
    Apr 2024
    Primary Completion
    Feb 2025
    Completion
    Mar 2026
    NCT06357832
  • Not applicable
    Recruiting

    Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment and Reduction of Heavy Drinking in Individuals With of Alcohol Use Disorder (AUD)

    Deep TMS (DTMS), Sham (No Treatment)

    Alcohol Use Disorder, Alcoholism +4

    Enrollment
    186
    Start
    Nov 2025
    Primary Completion
    Nov 2027est.
    Completion
    Dec 2027est.
    NCT07216872
Search ClinicalTrials.gov for “Brainsway”